Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

HRO761 (Alias: Werner syndrome RecQ helicase-IN-1, HRO-761)

Catalog No. T72107 Copy Product Info
Purity: 99.62%
🥰Excellent
Hot
HRO761 is a potent Werne r syndrome RecQ DNA deconjugase (WRN) inhibitor that can be used to study cancers such as colon and stomach cancer.

HRO761

Copy Product Info
🥰Excellent
Hot
Catalog No. T72107
Alias Werner syndrome RecQ helicase-IN-1, HRO-761

HRO761 is a potent Werne r syndrome RecQ DNA deconjugase (WRN) inhibitor that can be used to study cancers such as colon and stomach cancer.

HRO761
Cas No. 2869954-34-5
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$55In StockIn Stock
5 mg$127In StockIn Stock
10 mg$186In StockIn Stock
25 mg$312In StockIn Stock
50 mg$528In StockIn Stock
100 mg$787-In Stock
1 mL x 10 mM (in DMSO)$865In StockIn Stock
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.62%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
HRO761 is a potent Werne r syndrome RecQ DNA deconjugase (WRN) inhibitor that can be used to study cancers such as colon and stomach cancer.
Targets&IC50
WRN ATPase:100 nM, DLD1 WRN-KO cells:> 10 μM, SW48 cells:50 nM
In vitro
HRO761 exhibits an IC50 value of 100 nM for WRN ATPase, and demonstrates GI50 values of 50 nM and >10 μM for SW48 and DLD1 WRN-KO cell lines, respectively.[1]
SynonymsWerner syndrome RecQ helicase-IN-1, HRO-761
Chemical Properties
Molecular Weight702.08
FormulaC31H31ClF3N9O5
Cas No.2869954-34-5
SmilesC(C(NC1=C(Cl)C=C(C(F)(F)F)C=C1)=O)N2C=3N(C(=O)C(=C2CC)N4CCN(C(=O)C=5C(O)=C(C)N=CN5)CC4)N=C(N3)C=6CCOCC6
Storage & Solubility Information
Storagestore at low temperature,keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 99.7 mg/mL (142.01 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (4.7 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.4243 mL7.1217 mL14.2434 mL71.2170 mL
5 mM0.2849 mL1.4243 mL2.8487 mL14.2434 mL
10 mM0.1424 mL0.7122 mL1.4243 mL7.1217 mL
20 mM0.0712 mL0.3561 mL0.7122 mL3.5608 mL
50 mM0.0285 mL0.1424 mL0.2849 mL1.4243 mL
100 mM0.0142 mL0.0712 mL0.1424 mL0.7122 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy HRO761 | purchase HRO761 | HRO761 cost | order HRO761 | HRO761 chemical structure | HRO761 in vitro | HRO761 formula | HRO761 molecular weight